New Zealand - English - Ministry for Primary Industries

kela n.v. - penicillin g procaine - penicillin g procaine 300 g/litre - antibiotic

United States - English - NLM (National Library of Medicine)

international medication systems, limited - procainamide hydrochloride (unii: si4064o0lx) (procainamide - unii:l39wtc366d) - procainamide hydrochloride 100 mg in 1 ml - procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of procainamide treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. because procainamide has the potential to produce serious hematological disorders (0.5 percent) particularly leukopenia or agranulocytosis (sometimes fatal), its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment clearly outweigh the risks. (see warnings and boxed warning.) complete he

United States - English - NLM (National Library of Medicine)

hospira, inc. - procainamide hydrochloride (unii: si4064o0lx) (procainamide - unii:l39wtc366d) - procainamide hydrochloride 100 mg in 1 ml - procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of procainamide treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. because procainamide has the potential to produce serious hematological disorders (0.5 percent) particularly leukopenia or agranulocytosis (sometimes fatal), its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment clearly outweigh the risks. (see warnings and boxed warning.) complete he

United States - English - NLM (National Library of Medicine)

nexus pharmaceuticals llc - procainamide hydrochloride (unii: si4064o0lx) (procainamide - unii:l39wtc366d) - procainamide hydrochloride 1000 mg - procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of procainamide treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. because procainamide has the potential to produce serious hematological disorders (0.5 percent) particularly leukopenia or agranulocytosis (sometimes fatal), its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment clearly outweigh the risks. (see warnings and boxed warning.) complete hear

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - chloroprocaine hydrochloride 20 mg in 1 ml - chloroprocaine hydrochloride injection 2% and 3%, in single dose vials, without methylparaben preservative, without edta, is indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. chloroprocaine hydrochloride injection is not to be used for subarachnoid administration. chloroprocaine hydrochloride is contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.

United States - English - NLM (National Library of Medicine)

mckesson corporation - procainamide hydrochloride (unii: si4064o0lx) (procainamide - unii:l39wtc366d) - procainamide hydrochloride 100 mg in 1 ml - procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of procainamide treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. because procainamide has the potential to produce serious hematological disorders (0.5 percent) particularly leukopenia or agranulocytosis (sometimes fatal), its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment clearly outweigh the risks. (see warnings and boxed warning.) complete h

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875 nairobi kenya. plot no. 209/10349 - procaine penicillin and benzylpenicillin (as… - powder for injection - procaine penicillin 3000000 i.u and… - combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

agepha pharma s.r.o. - oxybuprocaine hydrochloride - eye drops, solution - oxybuprocaine

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - procainamide hydrochloride (unii: si4064o0lx) (procainamide - unii:l39wtc366d) - procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of procainamide treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. because procainamide has the potential to produce serious hematological disorders (0.5 percent) particularly leukopenia or agranulocytosis (sometimes fatal), its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment clearly outweigh the risks. (see warnings and box

United States - English - NLM (National Library of Medicine)

cardinal health - procainamide hydrochloride (unii: si4064o0lx) (procainamide - unii:l39wtc366d) - procainamide hydrochloride 100 mg in 1 ml